A

Apontis Pharma AG
XETRA:APPH

Watchlist Manager
Apontis Pharma AG
XETRA:APPH
Watchlist
Price: 9.64 EUR -1.43% Market Closed
Market Cap: 80.3m EUR
Have any thoughts about
Apontis Pharma AG?
Write Note

Income Statement

Earnings Waterfall
Apontis Pharma AG

Revenue
63.8m EUR
Cost of Revenue
-25.4m EUR
Gross Profit
38.5m EUR
Operating Expenses
-47.1m EUR
Operating Income
-8.7m EUR
Other Expenses
2.1m EUR
Net Income
-6.6m EUR

Income Statement
Apontis Pharma AG

Rotate your device to view
Income Statement
Currency: EUR
Dec-2021 Jun-2022 Dec-2022 Mar-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
51
N/A
55
+8%
56
+1%
66
+18%
37
-44%
28
-25%
51
+81%
64
+26%
Gross Profit
Cost of Revenue
(17)
(20)
(21)
(24)
(14)
(10)
(19)
(25)
Gross Profit
34
N/A
36
+5%
35
-1%
41
+19%
23
-44%
18
-23%
32
+77%
38
+21%
Operating Income
Operating Expenses
(29)
(31)
(32)
(40)
(33)
(28)
(41)
(47)
Selling, General & Administrative
(20)
(17)
(20)
(23)
(21)
(19)
(26)
(29)
Depreciation & Amortization
(2)
(2)
(2)
(2)
(2)
(1)
(3)
(3)
Other Operating Expenses
(8)
(12)
(10)
(15)
(10)
(7)
(12)
(15)
Operating Income
4
N/A
4
+2%
3
-27%
2
-44%
(10)
N/A
(10)
-1%
(9)
+10%
(9)
+0%
Pre-Tax Income
Interest Income Expense
(0)
0
0
0
(0)
0
0
0
Non-Reccuring Items
(4)
0
1
0
(6)
0
0
0
Total Other Income
(0)
(0)
0
0
0
0
(0)
(0)
Pre-Tax Income
0
N/A
4
+1 678%
4
-14%
2
-50%
(15)
N/A
(10)
+35%
(9)
+9%
(9)
+0%
Net Income
Tax Provision
(1)
(1)
(1)
(2)
4
2
2
2
Income from Continuing Operations
(1)
4
3
0
(11)
(7)
(7)
(7)
Net Income (Common)
(1)
N/A
4
N/A
3
-29%
1
-56%
(11)
N/A
(7)
+35%
(7)
+10%
(7)
+1%
EPS (Diluted)
-0.09
N/A
0.45
N/A
0.32
-29%
0.14
-56%
-1.33
N/A
-0.85
+36%
-0.77
+9%
-0.76
+1%

See Also

Discover More